The study is a phd-study comprising several substudies focusing on cardiac arrhythmias, mainly atrial fibrillation, among Greenlanders in Greenland. Some previous studies have indicated that the prevalence may be lower than among Westerners, however; studies have also indicated that atrial fibrillation is underdiagnosed. These studies aim to: * Estimate the prevalence of AF among Greenlanders in Greenland aged 55 years or older. * Estimate the prevalence of well-known risk factors among those found to have AF * Explore the symptoms of those affected by AF in Greenland * Among part of the participants: estimate the prevalence of autonomic neuropathy as this may cause arrhythmias.
Age range
50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Prevalence od cardiac arrhythmiaa / atrial fibrillation in the population older than 50 years
Timeframe: Completed within 6 months.
Prevalence of common symptoms of arrhythmias
Timeframe: Completed within 8 months
Prevalence of risk factors for AF
Timeframe: Completed within 8 months
Number of patients with ANS-neuropathy
Timeframe: Within 10 months